Table 1.
Patient characteristics and CDX2 expression.
| Factor | No. of Cases | CDX2 Expression | p-Value | ||
|---|---|---|---|---|---|
| Positive (n = 163) | Negative (n = 11) | ||||
| n (%) | n (%) | ||||
| Sex | Male | 102 | 97 (55.8) | 5 (2.9) | 0.364 |
| Female | 72 | 66 (37.9) | 6 (3.5) | ||
| Age (years) | <70 | 80 | 77(44.3) | 3(1.7) | 0.189 |
| ≥70 | 94 | 86(49.4) | 8(4.6) | ||
| Location | Right colon | 52 | 44 (25.3) | 8 (4.6) | <0.001 |
| Left colon | 73 | 73 (42.0) | 0 (0.0) | ||
| Rectum | 49 | 46 (26.4) | 3 (1.7) | ||
| T-factor | T 1–3 | 119 | 111 (63.8) | 8 (4.6) | 0.746 |
| T 4 | 55 | 52 (29.9) | 3 (1.7) | ||
| N-factor | N 0 | 95 | 91 (52.3) | 4 (2.3) | 0.201 |
| N + | 79 | 72 (41.4) | 7 (4.2) | ||
| Histology | Wel/Mod | 163 | 158 (90.8) | 5 (2.9) | <0.001 |
| Por/Sig/Muc | 11 | 5 (2.9) | 6 (3.5) | ||
| Lymphatic invasion | Ly 0 | 114 | 109 (62.6) | 5 (2.9) | 0.159 |
| Ly + | 60 | 54 (31.0) | 6 (3.5) | ||
| Venous invasion | V 0 | 68 | 65 (37.4) | 3 (1.7) | 0.396 |
| V + | 106 | 98 (56.3) | 8 (4.6) | ||
| Adjuvant chemotherapy | Yes | 89 | 82 (47.1) | 7 (4.0) | 0.389 |
| No | 85 | 81 (46.6) | 4 (2.3) | ||
Well: well differentiated adenocarcinoma; Mod: moderately differentiated adenocarcinoma; Por: poorly differentiated adenocarcinoma; Sig: signet ring cell carcinoma; Muc: mucinous adenocarcinoma.